Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Theresa Winhusen, Ph.D.
University of Cincinnati
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Synergy Treatment Center
Denver, Colorado, United States
- Gateway Community Services
Jacksonville, Florida, United States
- Operation Par, Inc.
St. Petersburg, Florida, United States
- Mountain Manor Treatment Programs
Baltimore, Maryland, United States
- Sstar: Stanley Street Treatment & Resources, Inc
Fall River, Massachusetts, United States
- Crittenton
Kansas City, Missouri, United States
- St. Luke'S-Roosevelt Hospital, Child and Family Institute
New York, New York, United States
- Rehab After Work-Life Counseling Services
Paoli, Pennsylvania, United States
- Addiction Medicine Services
Pittsburgh, Pennsylvania, United States
- Sstar of Rhode Island
North Kingstown, Rhode Island, United States
- Lradac
Columbia, South Carolina, United States
- Mental Health and Retardation of Tarrant County
Fort Worth, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2006
- Primary completion
- 31 Oct 2008
- Completion
- 31 Oct 2008
- Last update posted
- 7 Jun 2013
- Registered enrollment
- 303
- Registry id
- NCT00264797
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.